Xeris Biopharma Holdings Stock (NASDAQ: XERS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.51M |
Day Range | - - - |
52 Wk Range | 1.46 - 3.26 |
Market Cap | $442.75M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 7.36% |
Days to Cover | 8.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Xeris Biopharma Holdings has a consensus price target of $4.79.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $2.9715 last updated September 19, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Xeris Biopharma Holdings.
Xeris Biopharma Holdings’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.